The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Shapieva A.N.

Chair of Medical Informatics and Statistics, B.V. Petrovsky Russian Research Center of Surgery, Moscow, Russia

Kulagina T.Iu.

RNTsKh im. akad. B.V. Petrovskogo RAMN, Moskva

Belov Yu.V.

RNTsKh im. akad. B.V. Petrovskogo RAMN

Current approach in surgical treatment of obstructive hypertrophic cardiomyopathy

Authors:

Shapieva A.N., Kulagina T.Iu., Belov Yu.V.

More about the authors

Read: 4833 times


To cite this article:

Shapieva AN, Kulagina TIu, Belov YuV. Current approach in surgical treatment of obstructive hypertrophic cardiomyopathy. Russian Journal of Cardiology and Cardiovascular Surgery. 2017;10(6):52‑56. (In Russ.)
https://doi.org/10.17116/kardio201710652-56

Recommended articles:
Surgical access for thoracic and intrathoracic goiter. Piro­gov Russian Journal of Surgery. 2025;(1):54-61
En plaque convexity hype­rostotic meni­ngioma: 69 cases from a singlecenter. Burdenko's Journal of Neurosurgery. 2025;(1):20-29
Sepa­ration surgery in the treatment of spinal meta­stases. P.A. Herzen Journal of Onco­logy. 2025;(1):63-69
Surgical treatment of pulmonary tube­rculosis in children and adolescents. Piro­gov Russian Journal of Surgery. 2025;(3):16-23

References:

  1. Bogachev-Prokofev A, Heleznev S, Fomenko M, et al. Application extanded myoectomy in surgical treatment obstructive hypertrophic cardiomyopathy: immediate results. Pathology of blood circulation and cardiosurgery. 2015;19(2):20-25. (In Russ.)
  2. Bokeriya L. Hypertrophic obstructive cardiomyopathy. Annals of surgery. 2013;5:5-14. (In Russ.)
  3. Dzemeshkevich S, Frolova Yu, Kim S, et al. Anatomic and morphological signs of a diffuse-generalized hypertrophic cardiomyopathy. Russian Cardiology Journal. 2015;5:58-63. (In Russ.)
  4. Raskin V, Frolova Yu, Malikova M, et al. Tactics of surgical treatment of patients with the generalized form of obstructive hypertrophic cardiomyopathy. Clinical and experimental surgery. 2014;1:100-102. (In Russ.)
  5. Abhijeet B, Rajeev M, Anuj K, Sachin Y, Daljeet S, Sandeep N, Narasimhan C. A novel approach in the use of radiofrequency catheter ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy. Indian Heart J. 2016;68(5):618-623. https://doi.org/10.1016/j.ihj.2016.02.007
  6. Alam M, Dokainish H, Lakkis N. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies. J Interv Cardiol. 2006;319-27. https://doi.org/10.1111/j.1540-8183.2006.00153.x
  7. Cate F, Soliman O, Michel M, et al. Long-term outcome of alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: a word of caution. Circ Heart Fail. 2010;3(6):362-369. https://doi.org/10.1161/circheartfailure.109.862359
  8. Cirino A, Ho C, Pagon R, et al. Hypertrophic cardiomyopathy overview. Gene Reviews. University of Washington, Seattle. 1993 [2014].
  9. Cleland W. The surgical management of obstructive cardiomyopathy. J Cardiovascular Surgery.1963;4:489-491.
  10. Cooper R, Shahzad A, Hasleton J, et al. Radiofrequency ablation of the interventricular septum to treat outflow tract gradients in hypertrophic obstructive cardiomyopathy: a novel use of CARTO Sound technology to guide ablation. Europace. 2016;18:113-120. https://doi.org/10.1093/europace/euv302
  11. Cooley D. Surgical technique for hypertrophic left ventricular obstructive myopathy including mitral valve plication. J Cardiac Surgery. 1991;6:29-33. https://doi.org/10.1111/j.1540-8191.1991.tb00560.x
  12. Elliott P, Anastasakis A, Borger M, et al. ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy. Eur Heart J. 2014;35:2733-2779. https://doi.org/10.1093/eurheartj/ehu284
  13. Emmel M, Emmel M, Sreeram N. Radiofrequency catheter septal ablation for hypertrophic obstructive cardiomyopathy in children. Neth Hear J. 2005;448-451. https://doi.org/10.1007/s00392-005-0282-6
  14. Faber L, Welge D, Fassbender D, Schmidt H, Horstkotte D, Seggewiss H. One-year follow-up of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in 312 patients: predictors of hemodynamic and clinical response. Clin Res Cardiol. 2007;96:864-873. https://doi.org/10.1007/s00392-007-0578-9
  15. Frenneaux M. Assessing the risk of sudden cardiac death in a patient with hypertrophic cardiomyopathy. Heart. 2004;90(5):570-575. https://doi.org/10.1136/hrt.2003.020529
  16. Fernandes V, Nielsen C, Nagueh S, et al. Follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy the Baylor and Medical University of South Carolina experience 1996 to 2007. J Am Coll Cardiol Intv. 2008;1:561-570. https://doi.org/10.1016/j.jcin.2008.07.005
  17. Gersh B, Maron B, Bonow R, et al. ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. J Am Coll Cardiology. 2011;58(25):2703-2738. https://doi.org/10.1161/cir.0b013e318223e230
  18. Goodwin J, Hollman A, Bishop M. Clinical aspects of cardiomyopathy. BMJ.1961;14(1):69-79. https://doi.org/10.1136/bmj.1.5219.69
  19. Hensley N, Dietrich J, Nyhan D, et al. Hypertrophic cardiomyopathy: a review. Anesth Analg. 2015;120:554-569. https://doi.org/10.1097/sa.0000000000000211
  20. Houston B, Gerin R. Hypertrophic cardiomyopathy: a review. Clinical Medicine Insights. Cardiology. 2015;8:53-65. https://doi.org/10.4137/cmc.s15717
  21. Hsieh T, Patel К. Echocardiography-guided alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Anesth Analg. 2011;113:44-46. https://doi.org/10.1213/ane.0b013e31821a9fa6
  22. Johnson J, Dobell A, Scott H, MacLean L. In discussion of Dobell and Scott: hypertrophic subaortic stenosis: Evolution of a surgical technique. Thoracic and Cardiovas Surg. 1964;47:26-29.
  23. Kirklin J, Ellis F. Surgical relief of diffuse subvalvular aortic stenosis. Circulation. 1961;24:739-742. https://doi.org/10.1161/01.cir.24.4.739
  24. Lawrenz T, Borchert B, Leuner C, Bartelsmeier M, et al. Endocardial radiofrequency ablation for hypertrophic obstructive cardiomyopathy: acute results and 6 months-up in 19 patients. J Am Coll Cardiol. 2011;572-576. https://doi.org/10.1016/s0019-4832(12)60033-9
  25. Maron B. Commentary and re-appraisal: surgical septal myectomy vs. alcohol ablation: after a decade of controversy and mismatch between clinical practice and guidelines. Prog Cardiovasc Dis. 2012;54(6):523-528. https://doi.org/10.1016/j.pcad.2012.04.008
  26. Maron B, Maron M. Hypertrophic cardiomyopathy. Lancet. 2013;381:242-255. https://doi.org/10.1016/s0140-6736(12)60397-3
  27. Maron B, Carney K, Lever H, et al. Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy. J Am Coll Cardiology. 2003;41(6):974-980. https://doi.org/10.1016/s0735-1097(02)02976-5
  28. Messmer B. Extended myectomy for hypertrophic obstructive cardiomyopathy. Ann Thorac Surg. 1994;58(2):575-577. https://doi.org/10.1016/0003-4975(94)92268-3
  29. Morrow A, Brockenbrough E. Surgical treatment of idiopathic hypertrophic subaortic stenosis: technic and hemodynamic results of subaortic ventriculomyotomy. Ann Surg. 1961;154:181-189. https://doi.org/10.1097/00000658-196108000-00003
  30. Robbins R, Stinson E. Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy. J Thoracic Cardiovascular Surg. 1996;111:586-594. https://doi.org/10.1016/s0022-5223(96)70310-0
  31. Schaff H, Dearani J, Ommen S, et al. Expanding the indications for septal myectomy in patients with hypertrophic cardiomyopathy: results of operation in patients with latent obstruction. J Thorac Cardiovascular Surgery. 2012;143(2):303-309. https://doi.org/10.1016/j.jtcvs.2011.10.059
  32. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet. 1995;211-214. https://doi.org/10.1016/s0140-6736(95)91267-3
  33. Sherrid M, Chaudhry F, Swistel D. Obstructive hypertrophic cardiomyopathy: echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction. Ann Thorac Surg. 2003;75(5):620-632. https://doi.org/10.1016/s0003-4975(03)00500-9
  34. Sherrid M, Gunsburg D, Moldenhauer S, et al. Systolic anterior motion begins at low left ventricular outflow tract velocity in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiology. 2000;36:1344-1354. https://doi.org/10.1016/s0735-1097(00)00830-5
  35. Smedira N, Lytle B, Lever H, et al. Current effectiveness and risks of isolated septal myectomy for hypertrophic obstructive cardiomyopathy. Ann Thorac Surgery. 2008;85(1):127-133. https://doi.org/10.1016/j.athoracsur.2007.07.063
  36. Sorajja P, Binder J, Nishimura R, et al. Predictors of an optimal clinical outcome with alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Catheter Cardiovascular Interv. 2013;81(1):58-67. https://doi.org/10.1002/ccd.24328
  37. Sorajja P, Ommen S, Holmes D, et al. Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Circulation. 2012;126:2374-2380. https://doi.org/10.1161/circulationaha.111.076257
  38. Swaminathan M, Debruijn N, Glower D, et al. Unexpected transesophageal echocardiographic finding after septal myectomy. J Cardiothorac Vasc Anesth. 2002;16:384-385. https://doi.org/10.1053/jcan.2002.124154
  39. Swistel D, Balaram S. Surgical myectomy for hypertrophic cardiomyopathy in the 21st century, the evolution of the RPR repair: resection, plication, and release. Prog Cardiovasc Dis. 2012;54:498-502. https://doi.org/10.1016/j.pcad.2012.03.001
  40. Valeti U, Nishimura R, Holmes D, et al. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiology. 2007;49(3):350-357. https://doi.org/10.1016/j.jacc.2006.08.055
  41. Woo A, Rakowski H. Does myectomy convey survival benefit in hypertrophic cardiomyopathy? Heart Fail Clin. 2007;3:275-288. https://doi.org/10.1016/j.hfc.2007.04.010
  42. Yu E, Omran A, Wigle E, et al. Mitral regurgitation in hypertrophic obstructive cardiomyopathy: relationship to obstruction and relief with myectomy. J Am Coll Cardiology. 2000;36(7):2219-2225. https://doi.org/10.1016/s0735-1097(00)01019-6

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.